Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of January 7, 2025 • 5:00 AM ET

Date/Time Source News Release
11/16/2023 08:30 AM EST Business Wire Athersys Reports Third Quarter 2023 Financial Results and Business Highlights
10/16/2023 04:52 PM EDT Business Wire Athersys Extends Near Term Liquidity with Proceeds from Warrant Inducement and Global ARDS License with Healios to Explore Strategic Alternatives
10/10/2023 08:30 AM EDT Business Wire Athersys Reports Interim Analysis Results of MASTERS-2 Clinical Study with MultiStem in Ischemic Stroke, Signs Memorandum of Understanding (MOU) for Global ARDS License with Healios
10/03/2023 04:30 PM EDT Business Wire Athersys Licenses its Animal Health Assets to Ardent Animal Health
10/02/2023 05:04 PM EDT Business Wire Athersys Director Jane Wasman Appointed Board Chair
09/06/2023 02:45 PM EDT Business Wire Grant Awarded to Newcastle University to Research Athersys' MultiStem® in Machine Perfusion Prior to Kidney Transplantation
08/17/2023 09:30 PM EDT Business Wire Athersys, Inc. Announces Pricing of $3.5 Million Public Offering
08/16/2023 05:01 PM EDT Business Wire Athersys Reports Second Quarter 2023 Financial Results and Business Highlights
08/11/2023 08:00 AM EDT Business Wire Athersys Appoints Neema Mayhugh, PhD to its Board of Directors
07/31/2023 01:38 PM EDT Business Wire Athersys to Host Business Update Conference Call on August 9th
Page

Additional News

As of January 7, 2025 • 5:00 AM ET

Date/Time Source News Release
Page